NCT02802709View on ClinicalTrials.gov

A Trial of SB-061 in Osteoarthritis of the Knee

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

June 30, 2017

Conditions
Osteoarthritis
Interventions
DEVICE

SB-061

delivered via intra-articular injection

OTHER

Placebo

Placebo

Trial Locations (2)

10128

CCBR, Tallinn

50107

Medita Kliinik, Tartu

All Listed Sponsors
collaborator

Nordic Bioscience Clinical Development

UNKNOWN

lead

Symic OA Co.

INDUSTRY

NCT02802709 - A Trial of SB-061 in Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter